• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events > Best Science for the most neglected: Where do we stand 10 years on? > Page 2

Best Science for the most neglected: Where do we stand 10 years on?

4-5 December 2013

Institut Pasteur, Paris, France

  • Programme and Presentation
    • Overview
    • Programme and Presentations
    • Photos
    • Awards Ceremony
    • Press Release
    • Press Clippings
    • Symposium
    • Symposium Photos
    • Model Report
    • Collection

Programme and Presentations

5 DECEMBER CONFERENCE PROGRAMME 

Session Notes

Opening Session


M
oderator: Dr Pierre-Etienne Bost,Chair of DNDi Scientific Advisory Committee, formerly Institut Pasteur, France [Video]

Opening Addresses:

  • Prof. Christian Bréchot, President, Institut Pasteur, France [Video]
  • Prof. Marcel Tanner, Director, Swiss Tropical and Public Health Institute (Swiss TPH), Chair of DNDi Board of Directors, Switzerland [Video]
  • Dr Claire Rieux, Vice President, Médecins Sans Frontières, France [Video]
  • Dr Rhona MacDonald, Senior Editor, PLOS Medicine, UK [Video]


Keynote Presentation: Reflecting on ten years of progress in the fight against AIDS, TB and malaria

  • Prof Michel Kazatchkine, UN Secretary General Special Envoy on HIV/AIDS in Eastern Europe and Central Asia & Senior Fellow, Global Health Program, the Graduate Institute of International and Development Studies, Geneva, Switzerland [Video]

10 Years of Portfolio Building for Neglected Diseases: a PDP Experience

Chair: Dr Tim Wells, Chief Scientific Officer, Medicines for Malaria Venture (MMV), Switzerland [Video]  Overview Presentation: The Origins of DNDi

  • Yves Champey, Consultant and former Chair of DNDi Board of Directors, France [Video]

Perspectives Presentation:

10 Years of Portfolio Building for Neglected Diseases: A DNDi Experience

  • Prof. Simon Croft, Dean, Faculty of Infectious and Tropical Diseases, London School of Tropical Medicine and Hygiene, formerly Director of Research and Development, DNDi, UK [Video]
  • Dr Shing Chang, Consultant, and former Director of Research and Development, DNDi, USA [Video]
  • Dr Graeme Bilbe, Director of Research and Development, DNDi, Switzerland [Video]

 

Main Progress and Key Challenges in Drug Discovery for Infectious Diseases in the Past Decade

Chair: Prof. Alan Fairlamb, Professor of Biochemistry and Wellcome Principal Research Fellow, College of Life Sciences, University of Dundee, UK [Video]

Keynote Presentation:

Progress and Challenges in Infectious Diseases Drug Discovery 

  • Prof. Dyann Wirth, Richard Pearson Strong Professor of Infectious Diseases, Harvard University and The Broad Institute [Video]

Panel Discussion:

  • Dr James McKerrow, Director, Center for Discovery and Innovation in Parasitic Diseases, University of California, San Francisco USA [Video]
  • Prof. Philippe Sansonetti, Director, Molecular Microbial Pathogenesis, Institut Pasteur, France [Video]
  • Dr Gerald Spaeth, Head of Laboratory, Molecular Parasitology and Signaling Unit, Institut Pasteur, France [Video]
  • Dr Nick Cammack, Senior Vice President and Head of the Tres Cantos Medicines Development Campus at GSK, Spain [Video]
  • Q & A [Video]
Breakthroughs and Challenges in Clinical Development

Chair: Prof. Nick White, Professor of Tropical Medicine, Mahidol University, Thailand [Video]

Keynote Speech: Dr Elias Zerhouni, President, Global R&D, Sanofi, France [Video]

Panel Discussion:

  • Dr Lance Gordon, Director for Neglected Infectious Diseases in the Global Health Program, Bill & Melinda Gates Foundation, USA [Video]
  • Prof. Ogobora Doumbo, Director, Malaria Research and Training Centre, University of Bamako, Mali [Video]
  • Dr Leonard Sacks, Associate Director for Clinical Methodology, CDER, Food and Drug Administration (FDA), USA [Video]
  • Dr Jaideep A. Gogtay, Chief Medical Director, Cipla Ltd, India [Video]
  • Q & A [Video]
The Future of Research on Neglected Diseases


Chair:
Ms Ellen ‘t Hoen, Consultant, medicines law and policy, The Netherlands [Video]
Keynote Speech:
Dr Philippe Douste-Blazy, Chair of the Executive Board, UNITAID, France [Video]

Panel Discussion:

  • Dr Charles Clift, Senior Consulting Fellow, Centre on Global Health Security, Chatham House, UK [Video]
  • Dr Line Matthiessen, Head of Infectious Diseases and Public Health Unit, DG Research and Innovation, European Commission, Belgium [Video]
  • Dr Christophe Paquet, DTO/SAN Santé et protection sociale, Agence Française du Développement (AFD), France [Video]
  • Dr Joanne Liu, International President, Médecins Sans Frontières, Switzerland [Video]
  • Dr Bernard Pécoul, Executive Director, DNDi, Switzerland [Video]
  • Q & A [Video]
Awards Ceremony

Awards Ceremony for “Project of the Year” and “Partnership of the Year [Video]

Closing Session


Closing Remarks by the Representative of the French Government: Mr Djillali Annane
, Conseiller Recherche et Eduction de la Ministre des Affaires Sociales, France

Closing Remarks:
 Prof Marcel Tanner, Chair DNDi Board of Directors, Director Swiss Tropical and Public Health Institute, Switzerland [Video]

Pages: Page 1, Page 2, Page 3, Page 4, Page 5, Page 6, Page 7, Page 8, Page 9, Page 10

Other events

Loading...
30 January 2026

Online

Bridging gaps in neglected tropical diseases data

10-21 November 2025

Belém, Brazil

COP30

9-13 November 2025

Toronto, Canada

ASTMH 2025

6 November 2025, 3:00 PM Nairobi

Online

Bridging the gap between research and policy for NTDs amid a changing funding landscape

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films, and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license